Showing results (61-70 of 2,099) with videos related to
Sort By:
Pageof 210
Cellular Immunology|June 1, 1987
Suppression of IgG memory responses by T cells activated with the type 2 antigen polyvinylpyrrolidone (PVP)A M Van Buskirk, H Braley-MullenJournal of Immunology (Baltimore, Md. : 1950)|February 15, 1987
Characterization of helper T cells induced by the type 2 antigen polyvinylpyrrolidoneA M Van Buskirk, H Braley-MullenJournal of Immunology (Baltimore, Md. : 1950)|September 1, 1987
In vitro activation of specific helper and suppressor T cells by the type 2 antigen polyvinylpyrrolidone (PVP)A M Van Buskirk, H Braley-MullenInfection and Immunity|June 1, 1986
Primary murine immunoglobulin M responses to certain pneumococcal capsular polysaccharides consist primarily of anti-pneumococcal cell wall carbohydrate antibodiesR L Fairchild, K E Sterner, H Braley-MullenJournal of Immunology (Baltimore, Md. : 1950)|December 12, 2001
Role of TGFbeta in development of spontaneous autoimmune thyroiditis in NOD.H-2h4 miceH Braley-Mullen, K Chen, Y Wei, et al.International Immunology|June 1, 1994
Requirement for B cell-derived immunoglobulin for Th activation by the type 2 antigen polyvinylpyrrolidoneH Braley-Mullen, G N Milligan, A M Van BuskirkEuropean Journal of Immunology|March 1, 1990
Type 6 and 19 pneumococcal polysaccharides coupled to erythrocytes elicit pneumococcal cell wall-specific primary IgM responses and capsular polysaccharide-specific secondary IgG responsesG N Milligan, R L Fairchild, K E Sterner, et al.Journal of the American Academy of Dermatology|April 1, 1980
Current concepts in the classification of connective tissue diseases. Overlap syndromes and mixed connective tissue disease (MCTD)G C Sharp, P C AndersonThe Journal of Clinical Investigation|January 1, 1977
Antinuclear antibody with distinct specificity for polymyositisJ F Wolfe, E Adelstein, G C SharpArchives of Internal Medicine|September 1, 1983
Liver disease in mixed connective tissue diseaseJ B Marshall, N Ravendhran, G C SharpPageof 210